NCT02364258View on ClinicalTrials.gov

Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 27, 2017

Study Completion Date

December 27, 2017

Conditions
Dyslipidemia
Interventions
DRUG

Rosuvastatin

Rosuvastatin 10mg tablet (ages 8-21 years); 1 time dose given per oral at the start of the study day.

DRUG

Atorvastatin

Atorvastatin 10mg tablet (ages 8-21 years); 1 time dose given per oral at the start of the study day.

Trial Locations (1)

64108

Children's Mercy Hospital, Kansas City

All Listed Sponsors
lead

Children's Mercy Hospital Kansas City

OTHER

NCT02364258 - Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients | Biotech Hunter | Biotech Hunter